GRETCHEN JENKINS: Open Payments
NPI 1295985828 · GARRETT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,781 in 102 payments from 18 companies in 2025. Trend: 2023 $1,703 · 2024 $1,861 · 2025 $1,781
Food & beverage: $1,781
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $483 |
| ABBVIE INC. | 28 | $327 |
| Lilly USA, LLC | 8 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $141 |
| PFIZER INC. | 8 | $136 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Novo Nordisk Inc | 5 | $87 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Amgen Inc. | 3 | $45 |
| Exact Sciences Corporation | 3 | $42 |
Products named: BREZTRI, VRAYLAR, CAPLYTA, FARXIGA, Auvelity, ZEPBOUND, JARDIANCE, MOUNJARO.
Industry payments across IN — which companies pay providers there.
